The 30th patient also eventually recovered. Twenty-nine out of 30 moderate-to-severe COVID-19 patients who were administered a treatment developed by Tel Aviv’s Sourasky Medical Center (Ichilov Hospital) as part of a Phase I trial recovered from the disease and were released within three to five days, the hospital said Friday. The 30th patient also recovered but it took longer. The patients were given Prof. Nadir Arber’s EXO-CD24 COVID-19 treatment, which is based on CD24-enriched exosomes and is meant to fight